180 mL of blood is collected from patients to grow The T cells are grown and a retrovirus (a special virus that can insert the GPC3 CAR gene into the T cells) is used to genetically engineer them. After the CAR gene was put into the T cells, the investigators make sure that they are able to kill GPC-3 positive solid tumor cells in the laboratory.